Prete, Alessandro http://orcid.org/0000-0002-4821-0336
Bancos, Irina http://orcid.org/0000-0001-9332-2524
Article History
Accepted: 25 March 2024
First Online: 22 April 2024
Competing interests
: A.P. received research funding and consultancy fees from Recordati, Diurnal and HRA Pharma. I.B. reports consulting, advisory board or data safety monitoring board participation fees (to institution) from Diurnal, Neurocrine, Spruce, Adrenas, Recordati, Corcept, Sparrow, and HRA Pharma, NovoNordisk, AstraZeneca, Xeris outside this work. I.B. received research funding (to institution) from Recordati and HRA Pharma for investigator-initiated awards.